Production (Stage)
DarioHealth Corp.
DRIO
$0.7196
$0.00160.22%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 47.21% | 32.87% | -2.09% | -28.10% | -28.57% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 47.21% | 32.87% | -2.09% | -28.10% | -28.57% |
| Cost of Revenue | -8.05% | -12.39% | -13.81% | -30.29% | -29.96% |
| Gross Profit | 100.26% | 76.44% | 7.27% | -26.21% | -27.18% |
| SG&A Expenses | -7.53% | 10.30% | 19.45% | 16.28% | 4.00% |
| Depreciation & Amortization | 6.09% | 14.64% | 7.50% | 2.24% | -0.84% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.90% | 10.00% | 11.65% | 8.07% | 0.68% |
| Operating Income | 21.04% | -1.70% | -18.00% | -27.33% | -15.30% |
| Income Before Tax | 19.88% | 24.87% | 14.57% | 8.54% | 5.74% |
| Income Tax Expenses | 108.50% | -2,993.75% | -64,866.67% | -64,433.33% | -48,350.00% |
| Earnings from Continuing Operations | 16.69% | 28.07% | 17.93% | 11.89% | 9.01% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 16.69% | 28.07% | 17.93% | 11.89% | 9.01% |
| EBIT | 21.04% | -1.70% | -18.00% | -27.33% | -15.30% |
| EBITDA | 26.94% | 2.92% | -17.15% | -28.49% | -16.42% |
| EPS Basic | 64.62% | 66.22% | 53.94% | 45.72% | 28.43% |
| Normalized Basic EPS | 49.56% | 50.94% | 32.87% | 26.11% | 22.51% |
| EPS Diluted | 64.34% | 65.98% | 53.78% | 45.87% | 28.59% |
| Normalized Diluted EPS | 49.56% | 50.94% | 32.87% | 26.11% | 22.51% |
| Average Basic Shares Outstanding | 71.58% | 70.58% | 29.97% | 26.14% | 21.71% |
| Average Diluted Shares Outstanding | 71.58% | 70.58% | 29.97% | 26.14% | 21.71% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |